Akaza Research Announces Release of OpenClinica 1.1; Enhances Support for Windows

CAMBRIDGE, MA — July 17, 2006 — Akaza Research, the leading name in open source clinical trials software, is pleased to announce the release of OpenClinica 1.1. This release introduces automatic data warehousing to the Microsoft Windows version of the open source clinical research package. Automated data warehousing has been a standard feature of the Linux version of OpenClinica since its initial release.

“This interim release brings parity between our Linux and Windows versions,” said Cal Collins, CEO of Akaza Research. “While we remain committed to developing and releasing OpenClinica on Linux we recognize that many users run the software on MS Windows,” said Collins.

About OpenClinica™

OpenClinica™ is an open source web-based software platform that enables sponsors and investigators to manage clinical research data in multi-site studies. It facilitates protocol configuration, design of case report forms, electronic data capture, and study/data management. OpenClinica™ supports HIPAA and 21 CFR Part 11 guidelines and is designed as a fully standards-based, extensible, and modular platform. OpenClinica™ v1.0 was released in October 2005 under the GNU Lesser General Public License (LGPL). See http://www.OpenClinica.org. OpenClinica 2.0 is scheduled to be released in beta later this year.

About Akaza Research

Akaza Research, a leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the leading open source clinical trial data collection and management software platform. Akaza brings Open Source Software solutions to mainstream clinical research by making high quality, standards-based systems accessible for both private and public research. Akaza Research provides support, training, and consulting services to its customers worldwide. See http://www.akazaresearch.com.

# # #
MEDIA CONTACT: Steve Glines, sglines@industrialmyth.com, 978-952-6340

Back to News & Events index